Sector Setup

Set Up a Biotech & Pharma Company in Saudi Arabia

Saudi Arabia's National Biotechnology Strategy targets USD 35B sector GDP by 2040. Lifera (PIF), vaccine localisation, cell & gene therapy, genomics and biosimilars are priority sub-sectors. SFDA leads regulation.

How do I set up a biotech & pharma company in Saudi Arabia? 100%-foreign-owned LLC under MISA Industrial / Health. Capital SAR 5M – SAR 100M+. Year-one cost USD 50,000 – USD 200,000+ year-one. Timeline 20–40 weeks. Sector regulators: MISA, SFDA, MoH, MIM.

Biotech & Pharma sector entry in Saudi Arabia

Saudi Arabia's National Biotechnology Strategy targets USD 35B sector GDP by 2040. Lifera (PIF), vaccine localisation, cell & gene therapy, genomics and biosimilars are priority sub-sectors. SFDA leads regulation.

Recommended structure: 100%-foreign-owned LLC under MISA Industrial / Health. Capital requirement: SAR 5M – SAR 100M+. Saudization band needed: Premium required.

Tamra runs end-to-end biotech & pharma-sector setups — MISA, sector licensing, CR, banking, GR, ongoing compliance and workforce administration.

Key facts

SectorBiotech & Pharma
Recommended entity100%-foreign-owned LLC under MISA Industrial / Health
Capital requirementSAR 5M – SAR 100M+
Year-one costUSD 50,000 – USD 200,000+ year-one
Timeline20–40 weeks
Saudization bandPremium required
Sector regulatorsMISA, SFDA, MoH, MIM

Biotech & Pharma setup process

20–40 weeks

  1. Sector licensing pre-check. Verify the foreign parent's track record satisfies MISA, SFDA, MoH, MIM requirements before MISA submission.
  2. MISA application. Submit MISA application under the appropriate sector activity code, with full attested parent-company documentation.
  3. Sector regulator submission. Submit sector-specific licence applications in parallel with CR. MISA Industrial / Health licence drives the critical path.
  4. Commercial Registration & Chamber. MoC issues the CR; Chamber of Commerce subscription is activated.
  5. Operational portals. Activate Qiwa, Muqeem, GOSI, ZATCA, Mudad and any sector-specific portals.
  6. Banking & GM Iqama. Open Saudi corporate bank account; issue GM Iqama for the appointed manager.
  7. First hire / first invoice. Biotech & Pharma entity becomes operational. Tamra continues as the managed-services partner for payroll, GR and Iqama.

Mandatory sector licences

  • MISA Industrial / Health licence
  • SFDA manufacturer / GMP licensing
  • MoH facility licensing where clinical

Best-fit subsectors

  • Biosimilars manufacturing
  • Vaccine production
  • Cell & gene therapy
  • Genomics & diagnostics
  • Clinical-stage R&D

Common rejection reasons

  • GMP audit gap
  • Track-record evidence insufficient for the activity scope
  • SFDA registration pipeline not aligned with launch plan

Frequently asked questions

What's the cheapest way to enter Saudi Arabia's biotech & pharma market?

If you are testing the market, an EOR (hiring through Tamra's existing licence) is the lowest-commitment entry. For long-term presence, a 100%-foreign-owned LLC under MISA Industrial / Health is the standard. Tamra runs both routes.

What is the capital requirement for a biotech & pharma company?

SAR 5M – SAR 100M+

How long does biotech & pharma setup take?

20–40 weeks

What are the sector-specific licences required?

MISA Industrial / Health licence; SFDA manufacturer / GMP licensing; MoH facility licensing where clinical. Tamra coordinates these in parallel with MISA + CR.

Can Tamra act as the Saudi presence before our entity is ready?

Yes. Tamra holds an EOR licence and can sponsor your first 1–10 hires immediately, then transition them onto your entity once it is operational.

Related resources